European Medicines Agency approves first-line cabozantinib for advanced kidney cancer
Cabozantinib (Cabometyx) has been granted approval by the Committee for Medicinal [...]
Drinking alcohol may lower the risk of kidney cancer
In a recent study published in the International Journal of Cancer, researchers at [...]
Ipilimumab-nivolumab combination improves overall survival in metastatic kidney cancer
Overall survival data for the ipilimumab-nivolumab combination versus sunitinib from [...]
Obesity is on course to overtake smoking as the main preventable cause of cancer
Being overweight or obese is to blame for 23,000 cases [...]
Cancer immunotherapy
The following publication from Nature reviews various aspects of cancer immunotherapy, [...]
Open letter calling on Government to prioritise interests of cancer patients in Brexit negotiations
Kidney Cancer Support Network have come together with 18 other [...]
Financial cost of cancer is more than having a child
According to research carried out by Macmillan Cancer Support published [...]
Half of Britons mistakenly think stress causes cancer
A recent report published by the Work Cancer Research Fund [...]
Von Hippel-Lindau (VHL) disease and the risk for kidney cancer
Von Hippel-Lindau (VHL) disease is caused by a change (mutation) [...]
Oncolytic viruses for the treatment of cancer
Oncolytic viruses are modified versions of common viruses, such as [...]
